Archived
file from karymullis.com
Dr. Mullis biographical account
on the invention of PCR
Document retrieved on 21-Aug-2021
Note: This copy
is only for historical purposes, in case there are changes in the
original
site after publication (retrieved on 21-Aug-2021). The text has not
been altered, but only the main body and references are archived, the
format is more
plane here and some words are highlighted in bold. Please, refer to the
original
for a normal
reading in the original format.
Dr. Kary Banks Mullis (1944-2019)
Polymerase Chain Reaction
Making DNA accessible
Most people in molecular biology today are not old enough to remember
pre-PCR. But try to do your job without it, and you will see what a
difference that simple little technique has made.
'Polymerase Chain Reaction' is now a word in Merriam Webster's
Collegiate Dictionary and if you put 'PCR' into Google, you get
18,000,000 hits. If you type in 'pcr song,' you get a lovely little
ditty courtesy of Bio-Rad, which will rattle around in your brain like
an insane cat in your garage. Try it.
When I stumbled on PCR in the spring of 1983, I was trying to increase
the demand for oligonucleotides, which before automation my laboratory
had made by hand. Our new machine from my friend Ron Cook at Biosearch
across the San Francisco bay had threatened job stability in the
laboratory by doing what had taken us about three weeks to do, in eight
hours—and it did it every eight hours, no breaks.
My attempt succeeded. The demand went up by about a million and I
didn't have to fire any of my fellow lab workers at Cetus.
I was driving up a long and winding road between Cloverdale and
Booneville in Mendocino County, heading for my weekend cabin. My
girlfriend was asleep and I was functionally sober (or the road would
have proven my undoing) but it was late at night and I was feeling
weird. Strange things had happened to me on 128 before. Furtive old men
in…what was that? A grey robe. In that field. I didn't see anything. Or
lost time: the distinct feeling, shared by my former wife, pulling into
Booneville and recalling that we had just left Cloverdale, now thirty
five miles to the southeast. "Where have we been?" "I don't know; it
seems like we were just in Cloverdale." It was that kind of road, but
tonight, in the middle of that stretch at mileage marker 46.58, the
rest of my life was going to undergo a massive shift in just a few
minutes.
Oligonucleotides are amazing little things, but using only one, it is
not possible to physically locate a particular spot on human DNA. If
the human genome were random, a 17-nucleotide oligomer would uniquely
specify a position along the 6 to 7 billion bases in denatured human
DNA. But it's not random, and any 17-mer that is in there, is probably
in there more than once, or at least some slightly different version is
in there. There was no way to know that for sure in the early eighties,
and there are more complicated arguments for why this is so, but if you
looked at gels of whole human DNA broken into restriction fragments and
probed with 20-mers, you saw a lot of smears. No really sharp bands
like the restriction digests of bacteriophage DNA that you could use as
markers. They were sharp. So if you wanted to examine a human DNA
sequence closely, you had to clone it. Chop up the DNA into pieces of
several thousand base pairs, isolate each of those by growing them in a
particular bacterial colony, figure out which colony contained your
favorite piece, pick it off a plate and grow it up. That was the magic
of cloning, and it was magic. We all knew it. Even the janitors pushing
the brooms through the laboratories at night could feel it.
No one knew exactly what lay ahead. In the late seventies, just as I
started working for Cetus, a number of prominent molecular biologists
convinced the rest of the field to hold off a little to ponder the
safety issues. Conferences were called, laws were even passed in
Cambridge, Massachusetts and Berkeley, California. We were safely in
Emeryville, where there were gambling houses, but few laws. No one
could be sure that putting human genes into micro-organisms that could
possibly infect humans, was such a good idea. They never did figure it
out, but by way of compromising, some strains of E. coli were
designated to be more unlikely than others to be catastrophically
destructive to humans, and we agreed to use only those.
E. coli K12 didn't solve my problem with the new oligonucleotide
synthesis machine, neither did it solve the
problem of rapidly
determining whether or not the DNA of a growing fetus contained an
unfortunate mutation, giving the parents an opportunity to elect an
abortion.
Unconsciously combining the two problems, I started devising methods
whereby oligonucleotides could be used to determine single base pair
mutations from whole human DNA. Pregnant
mothers should not have to
wait for the cloners, and the result of running gels and using
radioactive probes on genomic DNA were fuzzy for reasons mentioned
above. Fuzzy is not a comfortable basis for
making a life or death
decision. Somebody needed to come up with a way to concentrate a
single
DNA locus in the presence of millions of similar but different DNA loci
without the inevitable delay of cloning.
It was going to happen tonight. That somebody was going to be me. In
ten years I would be toasting the health of the Swedish Royals in
Stockholm, grinning from ear to ear at my good fortune.
The California buckeyes poked heavy blossoms out into Highway 128. The
pink and white stalks hanging down into my headlights looked cold, but
they were loaded with warmed oils that dominated the dimension of
smell. It seemed to be the night of the buckeyes, but something else
was stirring.
My little silver Honda's front tires pulled us through the mountains.
My hands felt the road and the turns. My mind drifted back into the
laboratory. DNA chains coiled and floated. Lurid blue and pink images
of electric molecules injected themselves somewhere between the
mountain road and my eyes.
I see the lights on the trees, but most of me is watching something
else unfolding.
If a person were to attempt extending a synthetic oligonucleotide
prepared to be complementary to a target on human DNA by just one base,
using DNA polymerase and dideoxynucleoside triphosphates, using four
different tubes each containing all four bases, but only one of them in
each tube alpha-labeled with 32P, optimistically one might be able to
discover the identity of the nucleotide on the DNA target just
three-prime of the oligomer. Dideoxy-sequencing worked that
way…but…Huge but…that only worked on cloned DNA where the ratio of
target to non-target DNA was increased by a factor of about a million.
Fortunately for me I was thinking about other things that might go
wrong than just the brute improbability that only the right sequence
would be engaged. I paid just enough attention to this hypothetical
problem to plan on using two oligonucleotides, one designed for each
strand of the target sequence coming at the base pair in question from
either side. Although these two sides would be far distant in the
denatured reaction mixture they would still represent complementary
strands and if one told me that a 'T' was three-prime to one oligo, the
other should have told me 'A' was three-prime to the other. Not much of
a control, but I had oligos to burn. In fact that was what I was trying
to do. We had excess oligos on our hands.
I was worried about another possible problem. What if the DNA sample,
coming as it did from a person's tissue, was contaminated with
deoxynucleoside triphosphates of its own. Not especially unlikely, and
the sad fact was that DNA polymerase was not terribly fond of
dideoxies, when the natural substrate was around. Very likely it would
add a few deoxynucleotides to the proffered oligomer before getting
around to the dideoxies, labeled or not. This would destroy the
simplicity I was hoping for, a test that could be completed in one
shift in a hospital laboratory. So I started thinking of ways to get
rid of any possible stray nucleotides in the sample before I did the
experiment.
There were at least three misconceptions driving me towards PCR. I was
very close. But I didn't know what I was close to. I misconceived that
I was just solving some little technical detail. Good. I didn't clutch.
I don't think normal people can look directly at something that is
going to have a huge effect on them. We are better creeping up from the
side.
My second misconception was that the procedure I was planning would
work at all. The probabilities of the complexity of the sample, which
PCR was going to solve very shortly, were very much against it. I drove
on.
The third misconception was more subtle and was shared by my
colleagues. There is an enzyme that could have disposed of the
hypothetical stray deoxynucleoside triphosphates, bacterial alkaline
phosphatase. It would clip off their little triphosphate tails in a
flash, but then I would have to get rid of it, before I added my
precious dideoxies, or it would clip off their tails, too. Everyone
knew that BAP, as we referred to it, could not be irreversibly heat
denatured, so you couldn't get rid of it easily. The discovery of the
natural renaturation of heat denatured BAP was famous. It established
that the three-dimensional structure of a protein would refold based on
its sequence alone. There was a product called MAT-BAP on the market to
get rid of BAP after it was no longer desired in a reaction, by having
the protein attached to an insoluble matrix. I had never had any luck
with this product, and neither I, nor anyone else in the field,
realised that if you take a microliter of BAP from a commercial supply,
and use it quickly, before it loses its zinc atom into a buffer that
contains no appreciable zinc, it will work for a short time, and then
it will be subject to irreversible heat denaturation. I discovered that
much later, but fortunately did not know it at the time. The famous
refolding experiment was done in a high zinc buffer.
So I considered other ways to get rid of deoxynucleoside triphosphates.
Klenow! That would polymerise them, given an oligomer to start with and
some single-stranded DNA for a template. Klenow was the polymerase that
I had planned to use anyhow. How clever. I would use it twice for two
purposes. First I would denature my sample, separated into four tubes,
add the primers I would later use in the main event, bring to 37
degrees and wait. The polymerase should polymerise all the nucleotides.
Now I would heat the mixture to remove the oligos that may have been
extended indefinitely now, cool to 37 degrees, add some more polymerase
which would have been denatured by the heat, and add the
dideoxynucleotides. I had it…PCR, but I didn't see it yet.
There would be a vast excess of oligomers, now fresh ones would land on
the target strands and hopefully be extended by one radioactive
nucleotide. What could go wrong? What if the oligomers in the 'get rid
of the triphosphates' step had been extended a long way?
I very quickly brought the Honda to a stop near the roads edge, but
sticking out into the potential logging trucks. With me, my girlfriend
still asleep, and my new invention in peril, I contemplated what would
happen if they had been extended a long way. Their extension products
would be primed by the other oligos and these would also now be
extended.
I would have doubled the signal, and I could do that over and over, and
I could add a tremendous excess of my own deoxynucleoside triphosphates
as they are cheap, soluble in water and legal in California.
I'd better get out of the road.
A few hundred yards down 128 was a pullout. By the time I got there the
rest had fallen grandly into place. I could design the oligos some
distance from each other. After three cycles they would make a double
stranded DNA molecule corresponding exactly to the DNA template between
them, and that would double in concentration every subsequent cycle.
Anything else that happened would be of no concern. After ten cycles I
would have a thousand. I knew my powers of two, because I wrote
computer programs I understood the power of reiterative loops. Thirty
cycles would be somewhere around a billion. The product would overwhelm
anything that was unintended because it would be self catalytic, and
only the site of interest would bind the necessary two oligos together
in their little reproductive dance.
I didn't sleep that night. The next morning I bought two bottles of
Navarro Vineyards Pinot Noir, and by mid afternoon had settled into a
fitful sleep. There were diagrams of PCR reactions on every surface
that would take pencil or crayon in my cabin. I woke up in a new world.
By Dr. Kary Banks Mullis
Copyright 2009 Kary
Mullis
Return to Commentary